Terms: = Breast cancer AND MYB, c-myb_CDS, 4602, ENSG00000118513, P10242, efg, Cmyb, c-myb
191 results:
1. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.
Lin CJ; Jin X; Ma D; Chen C; Ou-Yang Y; Pei YC; Zhou CZ; Qu FL; Wang YJ; Liu CL; Fan L; Hu X; Shao ZM; Jiang YZ
Cancer Cell; 2024 Apr; 42(4):701-719.e12. PubMed ID: 38593782
[TBL] [Abstract] [Full Text] [Related]
2. Withaferin A alters the expression of microRNAs 146a-5p and 34a-5p and associated hub genes in MDA-MB-231 cells.
Shuaib M; Chaudhri S; Kumar S
Biomol Concepts; 2024 Jan; 15(1):. PubMed ID: 38525814
[TBL] [Abstract] [Full Text] [Related]
3. Characterization of mybL1 Gene in Triple-Negative breast cancers and the Genes' Relationship to Alterations Identified at the Chromosome 8q Loci.
Player A; Cunningham S; Philio D; Roy R; Haynes C; Dixon C; Thirston L; Ibikunle F; Boswell TA; Alnakhalah A; Contreras J; Bell M; McGuffery T; Bryant S; Nganya C; Kanu S
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473786
[TBL] [Abstract] [Full Text] [Related]
4. Solid basal adenoid cystic carcinoma of the breast: A case report and literature review.
Gou WB; Yang YQ; Song BW; He P
Medicine (Baltimore); 2024 Jan; 103(3):e37010. PubMed ID: 38241532
[TBL] [Abstract] [Full Text] [Related]
5. Impact of Mutations in Subunit Genes of the Mammalian SWI/SNF Complex on Immunological Tumor Microenvironment.
Hozumi C; Iizuka A; Ikeya T; Miyata H; Maeda C; Ashizawa T; Nagashima T; Urakami K; Shimoda Y; Ohshima K; Muramatsu K; Sugino T; Shiomi A; Ohde Y; Bando E; Furukawa K; Sugiura T; Mukaigawa T; Nishimura S; Hirashima Y; Mitsuya K; Yoshikawa S; Tsubosa Y; Katagiri H; Niwakawa M; Yamaguchi K; Kenmotsu H; Akiyama Y
Cancer Genomics Proteomics; 2024; 21(1):88-101. PubMed ID: 38151294
[TBL] [Abstract] [Full Text] [Related]
6. The mitotic checkpoint kinase BUB1 is a direct and actionable target of myb in adenoid cystic carcinoma.
Cicirò Y; Ragusa D; Nevado PT; Lattanzio R; Sala G; DesRochers T; Millard M; Andersson MK; Stenman G; Sala A
FEBS Lett; 2024 Jan; 598(2):252-265. PubMed ID: 38112379
[TBL] [Abstract] [Full Text] [Related]
7. Inhibition of CREB Binding and Function with a Dual-Targeting Ligand.
Liu Y; Joy ST; Henley MJ; Croskey A; Yates JA; Merajver SD; Mapp AK
Biochemistry; 2024 Jan; 63(1):1-8. PubMed ID: 38086054
[TBL] [Abstract] [Full Text] [Related]
8. Interactions between BRD4S, LOXL2, and MED1 drive cell cycle transcription in triple-negative breast cancer.
Pascual-Reguant L; Serra-Camprubí Q; Datta D; Cianferoni D; Kourtis S; Gañez-Zapater A; Cannatá C; Espinar L; Querol J; García-López L; Musa-Afaneh S; Guirola M; Gkanogiannis A; Miró Canturri A; Guzman M; Rodríguez O; Herencia-Ropero A; Arribas J; Serra V; Serrano L; Tian TV; Peiró S; Sdelci S
EMBO Mol Med; 2023 Dec; 15(12):e18459. PubMed ID: 37937685
[TBL] [Abstract] [Full Text] [Related]
9. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With myb Overexpression.
Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
[TBL] [Abstract] [Full Text] [Related]
10. Plasma microRNA-195, -34c, and - 1246 as novel biomarkers for the diagnosis of trastuzumab-resistant HER2-positive breast cancer patients.
Rezaei Z; Dastjerdi K; Allahyari A; ShahidSales S; Talebian S; Maharati A; Zangooie A; Zangouei AS; Sadri F; Sargazi S
Toxicol Appl Pharmacol; 2023 Sep; 475():116652. PubMed ID: 37557922
[TBL] [Abstract] [Full Text] [Related]
11. A novel camptothecin derivative, ZBH-01, exhibits superior antitumor efficacy than irinotecan by regulating the cell cycle.
Li Y; Zhao D; Zhang W; Yang M; Wu Z; Shi W; Lan S; Guo Z; Yu H; Wu D
J Transl Med; 2023 Jun; 21(1):422. PubMed ID: 37386467
[TBL] [Abstract] [Full Text] [Related]
12. Salivary Gland Secretory Carcinoma: Clinicopathologic and Genetic Characteristics of 215 Cases and Proposal for a Grading System.
Baněčková M; Thompson LDR; Hyrcza MD; Vaněček T; Agaimy A; Laco J; Simpson RHW; Di Palma S; Stevens TM; Brcic L; Etebarian A; Dimnik K; Majewska H; Stárek I; O'Regan E; Salviato T; Helliwell T; Horáková M; Biernat W; Onyuma T; Michal M; Leivo I; Skalova A
Am J Surg Pathol; 2023 Jun; 47(6):661-677. PubMed ID: 37070739
[TBL] [Abstract] [Full Text] [Related]
13. CRISPR/Cas9 screen uncovers functional translation of cryptic lncRNA-encoded open reading frames in human cancer.
Zheng C; Wei Y; Zhang P; Xu L; Zhang Z; Lin K; Hou J; Lv X; Ding Y; Chiu Y; Jain A; Islam N; Malovannaya A; Wu Y; Ding F; Xu H; Sun M; Chen X; Chen Y
J Clin Invest; 2023 Mar; 133(5):. PubMed ID: 36856111
[TBL] [Abstract] [Full Text] [Related]
14. A novel EWSR1-myb fusion in an aggressive advanced breast adenoid cystic carcinoma with mixed classical and solid-basaloid components.
Lei T; Shi Y; Da W; Xia C; Wang H
Virchows Arch; 2023 Nov; 483(5):717-722. PubMed ID: 36719454
[TBL] [Abstract] [Full Text] [Related]
15. Combinatorial transcriptional regulation of HEB/ZEB1/ASCL1 and mybL2 on Ras/ErbB signaling.
Zhong F; Chen T; Li B
Biochem Biophys Res Commun; 2022 Sep; 622():170-176. PubMed ID: 35932528
[TBL] [Abstract] [Full Text] [Related]
16. An enhancer variant associated with breast cancer susceptibility in Black women regulates TNFSF10 expression and antitumor immunity in triple-negative breast cancer.
Han YJ; Zhang J; Hardeman A; Liu M; Karginova O; Romero R; Khramtsova GF; Zheng Y; Huo D; Olopade OI
Hum Mol Genet; 2023 Jan; 32(1):139-150. PubMed ID: 35930348
[TBL] [Abstract] [Full Text] [Related]
17. Distinct clinicopathological and genomic features in solid and basaloid adenoid cystic carcinoma of the breast.
Ji J; Zhang F; Duan F; Yang H; Hou J; Liu Y; Dai J; Liao Q; Chen X; Liu Q
Sci Rep; 2022 May; 12(1):8504. PubMed ID: 35590093
[TBL] [Abstract] [Full Text] [Related]
18. myb RNA In Situ Hybridization Is a Useful Diagnostic Tool to Distinguish breast Adenoid Cystic Carcinoma From Other Triple-negative breast Carcinomas.
Butcher MR; White MJ; Rooper LM; Argani P; Cimino-Mathews A
Am J Surg Pathol; 2022 Jul; 46(7):878-888. PubMed ID: 35522890
[TBL] [Abstract] [Full Text] [Related]
19. A novel mutant PIK3R1
Wang K; Hu Y; Xu L; Zhao S; Song C; Sun S; Li X; Li M
Mol Biol Rep; 2022 Jul; 49(7):6155-6160. PubMed ID: 35384625
[TBL] [Abstract] [Full Text] [Related]
20. Actin-binding Rho activating C-terminal like (ABRACL) transcriptionally regulated by myb proto-oncogene like 2 (mybL2) promotes the proliferation, invasion, migration and epithelial-mesenchymal transition of breast cancer cells.
Li J; Chen H
Bioengineered; 2022 Apr; 13(4):9019-9031. PubMed ID: 35341461
[TBL] [Abstract] [Full Text] [Related]
[Next]
